Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5′-LTR region of the viral genome-Reference-Cited by-同舟云学术

Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5′-LTR region of the viral genome

Published:1995-12 Issue:2 Volume:166 Page:227-232
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Anazodo Michael I.,Salomon Horacio,Friesen Albert D.,Wainberg Mark A.,Wright Jim A.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference32 articles.

1. GEM 91 - an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS;Agrawal;Antisense Res. Dev.,1992

2. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus genome;Anazodo;J. Virol.,1995

3. Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioate;Anazodo;Leukemia,1995

4. Comparism of deoxynucleotide and tRNAlys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcriptase/template-switching reaction;Arts;J. Biol. Chem.,1994

5. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III);Arya;Science,1985

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delivery of oligonucleotides with lipid nanoparticles;Advanced Drug Delivery Reviews;2015-06

2. Terapia génica: opción terapéutica para neoplasias, infecciones y enfermedades monogénicas;Archivos Argentinos de Pediatria;2011-08

3. Targeting the HIV-1 RNA leader sequence with synthetic oligonucleotides and siRNA: Chemistry and cell delivery;Biochimica et Biophysica Acta (BBA) - Biomembranes;2006-03

4. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation;Journal of Controlled Release;2004-05

5. Delivery of an anti-HIV-1 ribozyme into HIV-infected cells via cationic liposomes;Biochimica et Biophysica Acta (BBA) - Biomembranes;1998-06